Barbara Withers
About Barbara Withers
Barbara Withers - Vice President of Clinical and Regulatory Strategy
Barbara Withers currently holds the title of Vice President of Clinical and Regulatory Strategy. She brings extensive experience in the pharmaceutical industry, where she has developed her expertise over more than 20 years. In her role, she is responsible for guiding clinical and regulatory strategies, ensuring compliance, and supporting the development of new drugs.
Academic Background and Education of Barbara Withers
Barbara Withers holds an impressive academic background, commencing with a B.S. in Biology from the University of Michigan. She furthered her education at Wayne State University School of Medicine, where she earned her Ph.D. in Molecular Biology and Genetics. During her academic journey, she performed post-doctoral research in cancer biology at Parke Davis/Warner Lambert, contributing significantly to her field.
Professional Experience of Barbara Withers
Barbara Withers has accumulated more than 20 years of experience in the pharmaceutical industry. Before her current position, she served as Vice President of Clinical Operations at Aerpio Pharmaceuticals. She has also held key roles at Pfizer, including Medical Writer, Drug Development Project Manager, Clinical Scientist, and Safety Risk Management Leader. Additionally, she worked as a Clinical Scientist at GE Healthcare and served as Site Head and Project Director at United Biosource Corporation.
Barbara Withers - Post-Doctoral Research in Cancer Biology
Barbara Withers performed post-doctoral research in cancer biology at Parke Davis/Warner Lambert. This research experience allowed her to deepen her understanding of molecular biology and genetics, contributing to her extensive knowledge base and expertise in the pharmaceutical industry.
Barbara Withers' Role at Pfizer
During her tenure at Pfizer, Barbara Withers held multiple positions that contributed to her well-rounded expertise. Her roles included Medical Writer, Drug Development Project Manager, Clinical Scientist, and Safety Risk Management Leader. Through these positions, she developed a comprehensive understanding of drug development processes, clinical operations, and safety risk management, greatly enhancing her capabilities in the pharmaceutical sector.